SEARCH

SEARCH BY CITATION

References

  • Andersen, P.K. & Vaeth, M. (1989) Simple parametric and nonparametric models for excess and relative mortality. Biometrics, 45, 523535.
  • Andersen, N.S., Pedersen, L., Elonen, E., Johnson, A., Kolstad, A., Franssila, K., Langholm, R., Ralfkiaer, E., Akerman, M., Eriksson, M., Kuittinen, O. & Geisler, C.H. (2003) Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant. European Journal of Haematology, 71, 7380.
  • Bhatia, S., Robison, L.L., Francisco, L., Carter, A., Liu, Y., Grant, M., Baker, K.S., Fung, H., Gurney, J.G., McGlave, P.B., Nademanee, A., Ramsay, N.K., Stein, A., Weisdorf, D.J. & Forman, S.J. (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood, 105, 42154222.
  • Bolwell, B., Kalaycio, M., Sobecks, R., Andresen, S., McBee, M., Kuczkowski, L., Rybicki, L. & Pohlman, B. (2002) Autologous hematopoietic cell transplantation non-Hodgkin’s lymphoma: 100 month follow-up. Bone Marrow Transplantation, 29, 673679.
  • Clark, T.G., Altman, D.G. & De Stavola, B.L. (2002) Quantification of the completeness of follow-up. Lancet, 359, 13091310.
  • Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society, 34, 187202.
  • Dreyling, M., Lenz, G., Hoster, E., Van Hoof, A., Gisselbrecht, C., Schmits, R., Metzner, B., Truemper, L., Reiser, M., Steinhauer, H., Boiron, J.M., Boogaerts, M.A., Aldaoud, A., Silingardi, V., Kluin-Nelemans, H.C., Hasford, J., Parwaresch, R., Unterhalt, M. & Hiddemann, W. (2005) Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood, 105, 26772684.
  • Freedman, A.S., Neuberg, D., Gribben, J.G., Mauch, P., Soiffer, R.J., Fisher, D.C., Anderson, K.C., Andersen, N., Schlossman, R., Kroon, M., Ritz, J., Aster, J. & Nadler, L.M. (1998) High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Journal of Clinical Oncology, 16, 1318.
  • Freedman, A.S., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Fisher, D.C., Schlossman, R., Alyea, E.P., Takvorian, T., Jallow, H., Kuhlman, C., Ritz, J., Nadler, L.M. & Gribben, J.G. (1999) Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood, 94, 33253333.
  • Geisler, C.H., Kolstad, A., Laurell, A., Andersen, N.S., Pedersen, L.B., Jerkeman, M., Eriksson, M., Nordstrom, M., Kimby, E., Boesen, A.M., Kuittinen, O., Lauritzsen, G.F., Nilsson-Ehle, H., Ralfkiaer, E., Akerman, M., Ehinger, M., Sundstrom, C., Langholm, R., Delabie, J., Karjalainen-Lindsberg, M.L., Brown, P. & Elonen, E. (2008) Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood, 112, 26872693.
  • Gopal, A.K., Rajendran, J.G., Petersdorf, S.H., Maloney, D.G., Eary, J.F., Wood, B.L., Gooley, T.A., Bush, S.A., Durack, L.D., Martin, P.J., Matthews, D.C., Appelbaum, F.R., Bernstein, I.D. & Press, O.W. (2002) High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma. Blood, 99, 31583162.
  • Gopal, A.K., Gooley, T.A., Maloney, D.G., Petersdorf, S.H., Eary, J.F., Rajendran, J.G., Bush, S.A., Durack, L.D., Golden, J., Martin, P.J., Matthews, D.C., Appelbaum, F.R., Bernstein, I.D. & Press, O.W. (2003) High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis. Blood, 102, 23512357.
  • Gorin, N.C., Coiffier, B., Hayat, M., Fouillard, L., Kuentz, M., Flesch, M., Colombat, P., Boivin, P., Slavin, S. & Philip, T. (1992) Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin’s lymphoma: a double-blind placebo-controlled trial. Blood, 80, 11491157.
  • Gyan, E., Foussard, C., Bertrand, P., Michenet, P., Le Gouill, S., Berthou, C., Maisonneuve, H., Delwail, V., Gressin, R., Quittet, P., Vilque, J.P., Desablens, B., Jaubert, J., Ramee, J.F., Arakelyan, N., Thyss, A., Molucon-Chabrot, C., Delepine, R., Milpied, N., Colombat, P. & Deconinck, E. (2009) High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood, 113, 9951001.
  • Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Gaulard, P. & Reyes, F. (1997) Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin’s lymphoma: updated results of the prospective study LNH87-2. Groupe d’Etude des Lymphomes de l’Adulte. Journal of Clinical Oncology, 15, 11311137.
  • Huang, B., Law, M.W. & Khong, P.L. (2009) Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology, 251, 166174.
  • Khouri, I.F., Romaguera, J., Kantarjian, H., Palmer, J.L., Pugh, W.C., Korbling, M., Hagemeister, F., Samuels, B., Rodriguez, A., Giralt, S., Younes, A., Przepiorka, D., Claxton, D., Cabanillas, F. & Champlin, R. (1998) Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. Journal of Clinical Oncology, 16, 38033809.
  • Klein, J. & Moeschberger, M.. (2003) Survival Analysis: Techniques of Censored and Truncated Data. Springer-Verlag, New York.
  • Lazarus, H.M., Rowlings, P.A., Zhang, M.J., Vose, J.M., Armitage, J.O., Bierman, P.J., Gajewski, J.L., Gale, R.P., Keating, A., Klein, J.P., Miller, C.B., Phillips, G.L., Reece, D.E., Sobocinski, K.A., Van Besien, K. & Horowitz, M.M. (1999) Autotransplants for Hodgkin’s disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology, 17, 534545.
  • Lazarus, H.M., Loberiza, F.R., Jr, Zhang, M.J., Armitage, J.O., Ballen, K.K., Bashey, A., Bolwell, B.J., Burns, L.J., Freytes, C.O., Gale, R.P., Gibson, J., Herzig, R.H., LeMaistre, C.F., Marks, D., Mason, J., Miller, A.M., Milone, G.A., Pavlovsky, S., Reece, D.E., Rizzo, J.D., Van Besien, K., Vose, J.M. & Horowitz, M.M. (2001) Autotransplants for Hodgkin’s disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplantation, 27, 387396.
  • Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. & Hudson, G.V. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomised trial. Lancet, 341, 10511054.
  • Majhail, N.S., Weisdorf, D.J., Defor, T.E., Miller, J.S., McGlave, P.B., Slungaard, A., Arora, M., Ramsay, N.K., Orchard, P.J., MacMillan, M.L. & Burns, L.J. (2006) Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin’s lymphoma. Biology of Blood and Marrow Transplantation, 12, 10651072.
  • Majhail, N.S., Ness, K.K., Burns, L.J., Sun, C.L., Carter, A., Francisco, L., Forman, S.J., Bhatia, S. & Baker, K.S. (2007) Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biology of Blood and Marrow Transplantation, 13, 11531159.
  • Ng, A.K. & Travis, L.B. (2008) Second primary cancers: an overview. Hematology/Oncology Clinics of North America, 22, 271289, vii.
  • Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier B, Biron.P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. New England Journal of Medicine, 333, 15401545.
  • Rabinowe, S.N., Neuberg, D., Bierman, P.J., Vose, J.M., Nemunaitis, J., Singer, J.W., Freedman, A.S., Mauch, P., Demetri, G., Onetto, N. et al (1993) Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies. Blood, 81, 19031908.
  • Ramlou-Hansen, H. (1983) Smoothing counting process intensities by means of kernel functions. Annals of Statistics, 11, 453466.
  • Sebban, C., Brice, P., Delarue, R., Haioun, C., Souleau, B., Mounier, N., Brousse, N., Feugier, P., Tilly, H., Solal-Celigny, P. & Coiffier, B. (2008) Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. Journal of Clinical Oncology, 26, 36143620.
  • Sodickson, A., Baeyens, P.F., Andriole, K.P., Prevedello, L.M., Nawfel, R.D., Hanson, R. & Khorasani, R. (2009) Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology, 251, 175184.
  • Sweetenham, J.W., Carella, A.M., Taghipour, G., Cunningham, D., Marcus, R., Della Volpe, A., Linch, D.C., Schmitz, N. & Goldstone, A.H. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin’s disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. Journal of Clinical Oncology, 17, 31013109.
  • Van Besien, K., Tabocoff, J., Rodriguez, M., Andersson, B., Mehra, R., Przepiorka, D., Dimopoulos, M., Giralt, S., Suki, S., Khouri, I., Spitzer, G., Jagannath, S., Dicke, K., Le Maistre, C.F., Deisseroth, A., Cabannillas, F., Champlin, R.E. (1995) High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. Bone Marrow Transplantation, 15, 549555.
  • Vandenberghe, E., Ruiz de Elvira, C., Loberiza, F.R., Conde, E., Lopez-Guillermo, A., Gisselbrecht, C., Guilhot, F., Vose, J.M., Van Biesen, K., Rizzo, J.D., Weisenburger, D.D., Isaacson, P., Horowitz, M.M., Goldstone, A.H., Lazarus, H.M. & Schmitz, N. (2003) Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. British Journal of Haematology, 120, 793800.
  • Vose, J.M., Zhang, M.J., Rowlings, P.A., Lazarus, H.M., Bolwell, B.J., Freytes, C.O., Pavlovsky, S., Keating, A., Yanes, B., Van Besien, K., Armitage, J.O. & Horowitz, M.M. (2001) Autologous transplantation for diffuse aggressive non-Hodgkin’s lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology, 19, 406413.
  • Vose, J.M., Rizzo, D.J., Tao-Wu, J., Armitage, J.O., Bashey, A., Burns, L.J., Christiansen, N.P., Freytes, C.O., Gale, R.P., Gibson, J., Giralt, S.A., Herzig, R.H., Lemaistre, C.F., McCarthy, P.L., Jr, Nimer, S.D., Petersen, F.B., Schenkein, D.P., Wiernik, P.H., Wiley, J.M., Loberiza, F.R., Lazarus, H.M., Van Biesen, K. & Horowitz, M.M. (2004) Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biology of Blood and Marrow Transplantation, 10, 116127.
  • Wadehra, N., Farag, S., Bolwell, B., Elder, P., Penza, S., Kalaycio, M., Avalos, B., Pohlman, B., Marcucci, G., Sobecks, R., Lin, T., Andresen, S. & Copelan, E. (2006) Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 13431349.